0001752724-23-046226.txt : 20230228 0001752724-23-046226.hdr.sgml : 20230228 20230228123536 ACCESSION NUMBER: 0001752724-23-046226 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 PERIOD START: 20230930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LOOMIS SAYLES FUNDS II CENTRAL INDEX KEY: 0000872649 IRS NUMBER: 043113285 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-06241 FILM NUMBER: 23682101 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-449-2810 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS I DATE OF NAME CHANGE: 20031119 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS DATE OF NAME CHANGE: 20031015 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS II DATE OF NAME CHANGE: 20030718 0000872649 S000006699 Loomis Sayles Growth Fund C000018227 Class A LGRRX C000018229 Class C LGRCX C000018230 Class Y LSGRX C000125484 Class N LGRNX NPORT-P 1 primary_doc.xml NPORT-P false 0000872649 XXXXXXXX S000006699 C000018229 C000125484 C000018227 C000018230 LOOMIS SAYLES FUNDS II 811-06241 0000872649 5493007QOEDY6IHOTU14 888 BOYLSTON STREET Suite 800 BOSTON 02199-8197 617-449-2139 Loomis Sayles Growth Fund S000006699 549300UJ1TECUW4GRJ92 2023-09-30 2022-12-31 N 8292266321.10 54251894.19 8238014426.91 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Salesforce Inc RCGZFPDMRW58VJ54VR07 Salesforce Inc 79466L302 1594007.00000000 NS USD 211349388.13000000 2.565537970407 Long EC CORP US N 1 N N N Expeditors International of Washington Inc 984500B055A804AB6E40 Expeditors International of Washington Inc 302130109 1574326.00000000 NS USD 163603957.92000000 1.985963479082 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 912650.00000000 NS USD 263555067.00000000 3.199254739577 Long EC CORP US N 1 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 101283515.40000000 PA USD 101283515.40000000 1.229465137486 Long RA CORP US N 2 Repurchase N 1.80000000 2023-01-03 107622500.00000000 USD 103309204.95000000 USD UST N N N PayPal Holdings Inc 5493005X2GO78EFZ3E94 PayPal Holdings Inc 70450Y103 1643618.00000000 NS USD 117058473.96000000 1.420954952174 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K305 3624036.00000000 NS USD 319748696.28000000 3.881380630210 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 Visa Inc 92826C839 2638647.00000000 NS USD 548205300.72000000 6.654580488828 Long EC CORP US N 1 N N N Alibaba Group Holding Ltd 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd 01609W102 1303968.00000000 NS USD 114866541.12000000 1.394347413920 Long EC CORP KY N 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 1670180.00000000 NS USD 104954111.20000000 1.274021939766 Long EC CORP US N 1 N N N Workday Inc 549300J0DYC0N31V7G13 Workday Inc 98138H101 553194.00000000 NS USD 92565952.02000000 1.123643965924 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 1694553.00000000 NS USD 406387700.46000000 4.933078280762 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA Corp 67066G104 2595312.00000000 NS USD 379278895.68000000 4.604008636365 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 670100205 1183378.00000000 NS USD 160158378.52000000 1.944138116544 Long EC CORP DK N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K107 1885042.00000000 NS USD 167259776.66000000 2.030340904886 Long EC CORP US N 1 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 753765.00000000 NS USD 152411283.00000000 1.850097306240 Long EC CORP US N 1 N N N Walt Disney Co/The 549300GZKULIZ0WOW665 Walt Disney Co/The 254687106 2712480.00000000 NS USD 235660262.40000000 2.860643963309 Long EC CORP US N 1 N N N Monster Beverage Corp 52990090AP0E7HCB6F33 Monster Beverage Corp 61174X109 3281463.00000000 NS USD 333166938.39000000 4.044262623547 Long EC CORP US N 1 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 771195104 4383043.00000000 NS USD 171596133.45000000 2.082979278228 Long EC CORP CH N 1 N N N Netflix Inc 549300Y7VHGU0I7CE873 Netflix Inc 64110L106 1117964.00000000 NS USD 329665224.32000000 4.001755850816 Long EC CORP US N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 480636.00000000 NS USD 127536762.60000000 1.548149298979 Long EC CORP US N 1 N N N Tesla Inc 54930043XZGB27CTOV49 Tesla Inc 88160R101 1593545.00000000 NS USD 196292873.10000000 2.382769232095 Long EC CORP US N 1 N N N Yum China Holdings Inc 529900DO9BYZ7VA3K502 Yum China Holdings Inc 98850P109 1274837.00000000 NS USD 69669842.05000000 0.845711580965 Long EC CORP US N 1 N N N FactSet Research Systems Inc 549300ZSJE7NBK6K9P30 FactSet Research Systems Inc 303075105 414813.00000000 NS USD 166427123.73000000 2.020233458032 Long EC CORP US N 1 N N N Deere & Co PWFTNG3EI0Y73OXWDH08 Deere & Co 244199105 194139.00000000 NS USD 83239037.64000000 1.010425975561 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 Meta Platforms Inc 30303M102 3399108.00000000 NS USD 409048656.72000000 4.965379222738 Long EC CORP US N 1 N N N Oracle Corp 1Z4GXXU7ZHVWFCD8TV52 Oracle Corp 68389X105 4773464.00000000 NS USD 390182947.36000000 4.736371255741 Long EC CORP US N 1 N N N Boeing Co/The RVHJWBXLJ1RFUBSY1F30 Boeing Co/The 097023105 2727812.00000000 NS USD 519620907.88000000 6.307598906146 Long EC CORP US N 1 N N N Autodesk Inc FRKKVKAIQEF3FCSTPG55 Autodesk Inc 052769106 1587699.00000000 NS USD 296693312.13000000 3.601514840285 Long EC CORP US N 1 N N N Starbucks Corp OQSJ1DU9TAOC51A47K68 Starbucks Corp 855244109 2222393.00000000 NS USD 220461385.60000000 2.676147117196 Long EC CORP US N 1 N N N Yum! Brands Inc 549300JE8XHZZ7OHN517 Yum! Brands Inc 988498101 1089524.00000000 NS USD 139546233.92000000 1.693930438676 Long EC CORP US N 1 N N N QUALCOMM Inc H1J8DDZKZP6H7RWC0H53 QUALCOMM Inc 747525103 1523991.00000000 NS USD 167547570.54000000 2.033834390878 Long EC CORP US N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 3318018.00000000 NS USD 115168404.78000000 1.398011690824 Long EC CORP CA N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 Regeneron Pharmaceuticals Inc 75886F107 310609.00000000 NS USD 224101287.41000000 2.720331329816 Long EC CORP US N 1 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 66987V109 2610550.00000000 NS USD 236829096.00000000 2.874832256015 Long EC CORP CH N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 4113802.00000000 NS USD 345559368.00000000 4.194692435487 Long EC CORP US N 1 N N N SEI Investments Co 5LJTIFADGZ6XH1RVOC11 SEI Investments Co 784117103 2362948.00000000 NS USD 137759868.40000000 1.672246020230 Long EC CORP US N 1 N N N 2023-01-27 LOOMIS SAYLES FUNDS II John Sgroi John Sgroi Assistant Treasurer XXXX NPORT-EX 2 NPORT_4830_83558226_1222.htm HTML

PORTFOLIO OF INVESTMENTS – as of December 31, 2022 (Unaudited)

Loomis Sayles Growth Fund

 

Shares

   

Description

   Value (†)  
                  

Common Stocks – 98.8% of Net Assets

  
    Aerospace & Defense – 6.3%

 

              2,727,812         Boeing Co. (The)(a)    $ 519,620,908      
      

 

 

 
    Air Freight & Logistics – 2.0%

 

    1,574,326     Expeditors International of Washington, Inc.         163,603,958  
      

 

 

 
    Automobiles – 2.8%

 

    1,862,773     Tesla, Inc.(a)      229,456,378  
      

 

 

 
    Beverages – 4.0%

 

    3,281,463     Monster Beverage Corp.(a)      333,166,938  
      

 

 

 
    Biotechnology – 5.9%

 

    310,609     Regeneron Pharmaceuticals, Inc.(a)      224,101,287  
    912,650     Vertex Pharmaceuticals, Inc.(a)      263,555,067  
      

 

 

 
         487,656,354  
      

 

 

 
    Capital Markets – 3.7%

 

    414,813     FactSet Research Systems, Inc.      166,427,124  
    2,362,948     SEI Investments Co.      137,759,868  
      

 

 

 
         304,186,992  
      

 

 

 
    Entertainment – 6.9%

 

    1,117,964     Netflix, Inc.(a)      329,665,224  
    2,712,480     Walt Disney Co. (The)(a)      235,660,263  
      

 

 

 
         565,325,487  
      

 

 

 
    Health Care Equipment & Supplies – 1.5%

 

    480,636     Intuitive Surgical, Inc.(a)      127,536,763  
      

 

 

 
    Hotels, Restaurants & Leisure – 5.2%

 

    2,222,393     Starbucks Corp.      220,461,385  
    1,274,837     Yum China Holdings, Inc.      69,669,842  
    1,089,524     Yum! Brands, Inc.      139,546,234  
      

 

 

 
         429,677,461  
      

 

 

 
    Interactive Media & Services – 10.9%

 

    3,624,036     Alphabet, Inc., Class A(a)      319,748,696  
    1,885,042     Alphabet, Inc., Class C(a)      167,259,777  
    3,399,108     Meta Platforms, Inc., Class A(a)      409,048,657  
      

 

 

 
         896,057,130  
      

 

 

 
    Internet & Direct Marketing Retail – 5.6%

 

    1,303,968     Alibaba Group Holding Ltd., Sponsored ADR(a)      114,866,541  
    4,113,802     Amazon.com, Inc.(a)      345,559,368  
      

 

 

 
         460,425,909  
      

 

 

 
    IT Services – 10.7%

 

    1,670,180     Block, Inc.(a)      104,954,111  
    1,643,618     PayPal Holdings, Inc.(a)      117,058,474  
    3,318,018     Shopify, Inc., Class A(a)      115,168,405  


Shares

   

Description

   Value (†)  
                  

Common Stocks – continued

  
    IT Services – continued

 

              2,638,647         Visa, Inc., Class A    $ 548,205,301      
      

 

 

 
         885,386,291  
      

 

 

 
    Life Sciences Tools & Services – 1.9%

 

    753,765     Illumina, Inc.(a)      152,411,283  
      

 

 

 
    Machinery – 1.0%

 

    194,139     Deere & Co.      83,239,038  
      

 

 

 
    Pharmaceuticals – 6.8%

 

    2,559,176     Novartis AG, Sponsored ADR      232,168,447  
    1,183,378     Novo Nordisk A/S, Sponsored ADR      160,158,379  
    4,307,296     Roche Holding AG, Sponsored ADR      168,630,638  
      

 

 

 
         560,957,464  
      

 

 

 
    Semiconductors & Semiconductor Equipment – 6.6%

 

    2,595,312     NVIDIA Corp.      379,278,896  
    1,523,991     QUALCOMM, Inc.      167,547,570  
      

 

 

 
         546,826,466  
      

 

 

 
    Software – 17.0%

 

    1,587,699     Autodesk, Inc.(a)      296,693,312  
    1,694,553     Microsoft Corp.      406,387,701  
    4,773,464     Oracle Corp.      390,182,947  
    1,594,007     Salesforce, Inc.(a)      211,349,388  
    553,194     Workday, Inc., Class A(a)      92,565,952  
      

 

 

 
         1,397,179,300  
      

 

 

 
    Total Common Stocks
(Identified Cost $5,922,939,334)
     8,142,714,120  
      

 

 

 

Principal
Amount

            
                  

Short-Term Investments – 1.2%

  
$     101,283,515     Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 12/30/2022 at 1.800% to be repurchased at $101,303,772 on 1/03/2023 collateralized by $107,622,500 U.S. Treasury Note, 3.250% due 6/30/2029 valued at $103,309,205 including accrued interest(b)
(Identified Cost $101,283,515)
     101,283,515  
      

 

 

 
    Total Investments – 100.0%
(Identified Cost $6,024,222,849)
     8,243,997,635  
    Other assets less liabilities – (0.0)%      (1,150,428
      

 

 

 
    Net Assets – 100.0%    $ 8,242,847,207  
      

 

 

 


(†)

Registered investment companies are required to value portfolio investments using an unadjusted, readily available market quotation. The Fund obtains readily available market quotations from independent pricing services. Fund investments for which readily available market quotations are not available are priced at fair value pursuant to the Fund’s Valuation Procedures. The Board of Trustees has approved a valuation designee who is subject to the Board’s oversight.

Unadjusted readily available market quotations that are utilized for exchange traded equity securities (including shares of closed-end investment companies and exchange-traded funds) include the last sale price quoted on the exchange where the security is traded most extensively. Shares of open-end investment companies are valued at net asset value per share.

Exchange traded equity securities for which there is no reported sale during the day are fair valued at the closing bid quotation as reported by an independent pricing service. Unlisted equity securities (except unlisted preferred equity securities) are fair valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be fair valued using evaluated bids furnished by an independent pricing service, if available.

Debt securities and unlisted preferred equity securities are fair valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers. Broker-dealer bid prices may be used to fair value debt and unlisted equities where an independent pricing service is unable to price an investment or where an independent pricing service does not provide a reliable price for the investment.

The Fund may also fair value investments in other circumstances such as when extraordinary events occur after the close of a foreign market, but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing a Fund’s investments, the valuation designee may, among other things, use modeling tools or other processes that may take into account factors such as issuer specific information, or other related market activity and/or information that occurred after the close of the foreign market but before the time the Fund’s net asset value (“NAV”) is calculated. Fair valuation by the Fund’s valuation designee may require subjective determinations about the value of the investment, and fair values used to determine a Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same investments. In addition, the use of fair value pricing may not always result in adjustments to the prices of investments held by a Fund.

The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.

 

(a)

Non-income producing security.

 

(b)

The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of December 31, 2022, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

 

ADR

An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.


Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 — quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 — prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 — prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The Fund’s pricing policies have been approved by the Board of Trustees. Investments for which market quotations are readily available are categorized in Level 1. Other investments for which an independent pricing service is utilized are categorized in Level 2. Broker-dealer bid prices for which the Fund has knowledge of the inputs used by the broker-dealer are categorized in Level 2. All other investments, including broker-dealer bid prices for which the Fund does not have knowledge of the inputs used by the broker-dealer, as well as investments fair valued by the valuation designee, are categorized in Level 3. All Level 2 and 3 securities are defined as being fair valued.

Under certain conditions and based upon specific facts and circumstances, the Fund’s valuation designee may determine that a fair valuation should be made for portfolio investment(s). These valuation designee fair valuations will be based upon a significant amount of Level 3 inputs.


The following is a summary of the inputs used to value the Fund’s investments as of December 31, 2022, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks*

   $ 8,142,714,120      $ —        $ —        $ 8,142,714,120  

Short-Term Investments

     —          101,283,515        —          101,283,515  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 8,142,714,120      $ 101,283,515      $ —        $ 8,243,997,635  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.


Industry Summary at December 31, 2022 (Unaudited)

 

Software

     17.0

Interactive Media & Services

     10.9  

IT Services

     10.7  

Entertainment

     6.9  

Pharmaceuticals

     6.8  

Semiconductors & Semiconductor Equipment

     6.6  

Aerospace & Defense

     6.3  

Biotechnology

     5.9  

Internet & Direct Marketing Retail

     5.6  

Hotels, Restaurants & Leisure

     5.2  

Beverages

     4.0  

Capital Markets

     3.7  

Automobiles

     2.8  

Air Freight & Logistics

     2.0  

Other Investments, less than 2% each

     4.4  

Short-Term Investments

     1.2  
  

 

 

 

Total Investments

     100.0  

Other assets less liabilities

     (0.0 )* 
  

 

 

 

Net Assets

     100.0
  

 

 

 

 

*

Less than 0.1%